Titleist Capital’s ResMed RMD Stock Holding History

Titleist Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-846	Closed	-$205K	–	274
2022 Q1	$205K	Sell	846 -60	-7%	-$14.5K	0.04%	241
2021 Q4	$236K	Buy	+906	New	+$235K	0.05%	206

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Titleist Capital's RMD Position: Q2 2022 in Review

Titleist Capital sold out of ResMed (RMD) in Q2 2022, closing a stake of 846 shares — an estimated $205K sold.

Titleist Capital first reported a position in RMD in Q4 2021 and held it in 2 quarters. The position peaked at $236K in Q4 2021. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

Titleist Capital reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
Titleist Capital sold 846 ResMed shares in Q2 2022, an estimated $205K.
Titleist Capital first reported a position in ResMed in Q4 2021 and held it in 2 quarters.
Titleist Capital's ResMed position peaked at $236K in Q4 2021.
676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Titleist Capital's 13F filing for Q2 2022, filed 15 Aug 2022.